CIPDB › China Industry › Chemicals › Pharmaceutical Intermediate
Muscle Building Retatrutide Peptide Retatrutide1
Pharmaceutical IntermediateRetatrutidePeptide Retatrutide
Xi'an Sase Biotechnology Co., Ltd
Preview:
Product DescriptionMuscle Building Retatrutide Peptide Retatrutide Product DescriptionProduct DetailsProduct NameRetatrutideAppearanceWhie PowderCAS2381089-83-2MfC221H342N46O68MW4731.35Rita lutide is a polypeptide drug composed of 39 amino acids and belongs to the GLP-1R/GIPR/GCGR triple receptor agonist. Its design inspiration comes from endogenous lnsulin stimulating hormone (such as GIP), and through structural optimization, it can simultaneously activate the following three receptors: GLP-1 receptor (GLP-1R) : promotes lnsulin secretion, inhibits glucagon release, delays gastric emptying, and enhances satiety; GIP receptor (GIPR) : Enhances lnsulin sensitivity, regulates lipid metabolism, and may work in synergy with GLP-1R to enhance weight loss effects; Glucagon receptor (GCGR) : Promotes energy expenditure, enhances liver gluconeogenesis inhibition, and reduces liver fat deposition.This multi-target synergistic effect enables it to demonstrate superior potential in metabolic regulation compared to traditional GLP-1 single-target drugs , especially in weight loss, blood sugar reduction and liver fat improvement, where it has unique advantages.Application&Function1. Multiple action mechanisms:(1) GLP-1 receptor activation: Retalutide activates the GLP-1 receptor, promoting lnsulin secretion and inhibiting glucagon release, thereby helping to lower blood sugar, delay gastric emptying and reduce appetite.(2)GIP receptor activation: GIP receptor activation can enhance the secretion effect of lnsulin and help further lower blood sugar.2. Glucagon receptor activation: The activation of glucagon receptors can promote fat breakdown and energy metabolism, thereby facilitating weight loss.3. Significant weight loss effect: Retalutide has demonstrated remarkable weight loss effects in clinical studies and is particularly suitable for obese patients or those with metabolic syndrome. Due to its multiple mechanisms of action, it performs outstandingly in reducing body fat and controlling weight.4. Blood sugar control: Retalutide can effectively lower blood sugar levels and is particularly suitable for type 2 diabetes patients who need blood sugar control. It can help improve lnsulin sensitivity and reduce postprandial blood sugar fluctuations.5. Cardiovascular health potential: Although retalutide is still in the clinical research stage, early data suggest that it may have the potential to reduce the risk of cardiovascular events, similar to the cardiovascular protective effects of other GLP-1 drugs.6. Injection administration: Retalutide is currently administered subcutaneously, typically as a long-acting formulation once a week. This administration frequency helps improve patient compliance.7. Side effects: Common side effects include gastrointestinal symptoms such as nausea, vomiting and diarrhea, similar to those of other GLP-1 drugs. These symptoms are relatively common in the early stage of treatment, but as the treatment time extends, patients usually gradually adapt.Specification
Purchasing Agent
Note: Send your message to supplier or manufacturer.
Welcome to our Professional and comprehensive procurement services...